Stringfellow D A
Arch Dermatol Res. 1981;270(2):141-55. doi: 10.1007/BF00408224.
As indicated in Table 1, two approaches have been taken to the development of antiviral chemotherapeutic agents. Both have met with some success although the availability of effective chemotherapeutic agents for the treatment of virus infections is very limited. This situation should change in the near future as more specific, direct inhibitors of virus replication are identified and better ways are developed for stimulating specific and nonspecific host defense mechanisms although the discussion of host defenses centered upon the interferon system, there are a variety of other nonspecific host defense mechanisms that are also important including macrophages, lymphocyte subpopulations, and other as yet poorly defined soluble mediators.
如表1所示,抗病毒化疗药物的研发采用了两种方法。尽管用于治疗病毒感染的有效化疗药物非常有限,但这两种方法都取得了一些成功。随着更多特异性、直接的病毒复制抑制剂被发现,以及刺激特异性和非特异性宿主防御机制的更好方法被开发出来,这种情况在不久的将来应该会有所改变。尽管宿主防御的讨论主要集中在干扰素系统上,但还有多种其他非特异性宿主防御机制也很重要,包括巨噬细胞、淋巴细胞亚群以及其他尚未明确的可溶性介质。